| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 03/28/2007 | EP1766025A1 Porcine sulfotransferase 2a1 polynucleotide sequence, protein, and methods of use for same |
| 03/28/2007 | EP1766017A1 Tumor specific antibody |
| 03/28/2007 | EP1766015A1 Polynucleotides encoding acetylcholine-gated chloride channel subunits of caenorhabditis elegans |
| 03/28/2007 | EP1765997A2 Pharmaceutical composition for modulating the activity of triglyceride hydrolase |
| 03/28/2007 | EP1765991A1 Acetyl coa carboxylase splice variant and uses thereof |
| 03/28/2007 | EP1765873A1 Methods and compositions using cd3 agonists |
| 03/28/2007 | EP1765872A1 Glycosylated immunoglobulin and immunoadhesin comprising the same |
| 03/28/2007 | EP1765871A1 N-glycosylated antibody |
| 03/28/2007 | EP1765870A2 Human monoclonal antibodies to fc gamma receptor i (cd64) |
| 03/28/2007 | EP1765869A1 Antigen binding proteins directed against scavenger receptor b1 that inhibit hcv replication |
| 03/28/2007 | EP1765868A2 Transferrin receptor antibodies |
| 03/28/2007 | EP1765867A1 Monoclonal antibodies to hiv-1 vpr and methods of using same |
| 03/28/2007 | EP1765865A2 Soluble zcytor14, anti-zcytor14 antibodies and binding partners and methods of using in inflammation |
| 03/28/2007 | EP1765862A2 Heparin binding peptide |
| 03/28/2007 | EP1765861A2 Fgfr binding peptides |
| 03/28/2007 | EP1765849A1 Process for protein isolation |
| 03/28/2007 | EP1765403A2 Combined active and passive targeting of biologically active agents |
| 03/28/2007 | EP1765402A2 Methods and compositions for enhancement of immunity by in vivo depletion of immunosuppressive cell activity |
| 03/28/2007 | EP1765401A2 Antibodies against human interleukin-13 and uses therefor |
| 03/28/2007 | EP1765400A2 Method for treating lupus |
| 03/28/2007 | EP1765398A2 Human antibodies interacting with hiv gp41 |
| 03/28/2007 | EP1765397A2 LIGANDS BINDING THE COMPLEX OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR (uPA) AND ITS RECEPTOR (uPAR) THAT INHIBIT DOWNSTREAM uPAR INTERACTIONS: IDENTIFICATION AND USE IN DIAGNOSIS OR THERAPY |
| 03/28/2007 | EP1765396A2 Antibodies |
| 03/28/2007 | EP1765395A1 Anti-gluten egg yolk antibodies for the treatment of celiac disease |
| 03/28/2007 | EP1765378A2 Agent capable of downregulating an msf-a-dependent hif-1a anduse thereof in cancer treatment |
| 03/28/2007 | EP1765061A2 Citrus sudden death |
| 03/28/2007 | EP1634077A4 Micropositioning cells for tissue engineering |
| 03/28/2007 | EP1587835A4 Antibodies specific for plasmacytoid dendritic cells |
| 03/28/2007 | EP1403371B1 Polypeptide having a cell death inhibitory activity |
| 03/28/2007 | EP1059089B1 Preventives/remedies for inflammatory intestinal disease |
| 03/28/2007 | EP1010759B1 Non-b non-c non-g hepatitis virus gene, polynucleotide, polypeptide, virion, method for separating virion, and method for detecting virus |
| 03/28/2007 | EP0871887B1 Electrochemiluminescent enzyme immunoassay |
| 03/28/2007 | CN1938428A Plasmid system for multigene expression |
| 03/28/2007 | CN1938046A Monomethylvaline compounds capable of conjugation to ligands |
| 03/28/2007 | CN1938045A Methods of therapy for solid tumors expressing the cd40 cell-surface antigen |
| 03/28/2007 | CN1935996A H9 subtype highly pathogenic avian influenza virus hemagglutinin gene antigen protein |
| 03/28/2007 | CN1935995A H7 subtype highly pathogenic avian influenza virus hemagglutinin gene antigen protein |
| 03/28/2007 | CN1935845A Coli flagellum polyclonal antibody, and its preparing method and use |
| 03/28/2007 | CN1935844A Coli obtrite holosomatic polyclonal antibody, and its preparing method and use |
| 03/28/2007 | CN1935843A Coli somatic polyclonal antibody, and its preparing method and use |
| 03/28/2007 | CN1935842A Coli common pili polyclonal antibody, and its preparing method and use |
| 03/28/2007 | CN1935841A Anti hepatitis B virus chicken yolk immune globulin IgY and its separating method |
| 03/28/2007 | CN1935840A Human receptor proteins; related reagents and methods |
| 03/28/2007 | CN1935260A Human antibodies that bind human tnfalpha |
| 03/28/2007 | CN1307301C A single-chain antibody method for dioxin detection |
| 03/28/2007 | CN1307201C Coupled substance between Lidamycin and segments of monoclonal antibody 3G11, 3G11Fab' |
| 03/28/2007 | CN1306963C Remedy for diseases caused by IL-6 production |
| 03/28/2007 | CN1306956C Molecular mimetics of meningococcal B epitopes which elicit functionally active antibodies |
| 03/27/2007 | US7196187 Method for producing antibody fragments |
| 03/27/2007 | US7196185 Preparing immunoglobulin as oral vaccines for cattle; animal husbandry; forensics |
| 03/27/2007 | US7196181 made in non-thyroidal eukaryotic cells; for diagnosis and treatment of immune disorders such as Hashimoto's thyroiditis |
| 03/27/2007 | US7196177 regulator controlling inflammatory cytokines in rheumatoid athritis |
| 03/27/2007 | US7196176 Nucleotide sequences coding membrane protein for use as antiproliferative/antitumor/antiinflammatory/anticarcinogenic agents |
| 03/27/2007 | US7196175 Antibodies to JTT-1 protein and cells secreting such antibodies |
| 03/27/2007 | US7196174 PRO1557 polypeptide encoded by a nucleic acid highly expressed in esophageal and kidney tumors |
| 03/27/2007 | US7196173 PRO1315 polypeptide encoded by a nuclear acid highly expressed in esophageal tumors |
| 03/27/2007 | US7196171 Alstrom syndrome is a homogeneous autosomal recessive disorder characterized by childhood obesity associated with hyperinsulinemia, chronic hyperglycemia, and neurosensory deficiency; isolated polypeptide |
| 03/27/2007 | US7196168 Metalloprotease-disintegrin ADAM23 (SVPH3-17) |
| 03/27/2007 | US7196164 Comprises nucleotide sequences coding signal sequence polypeptides for diagnosis, prevention and treatment of cell proliferative, cardiovascular and infectious disorders |
| 03/27/2007 | US7196163 Assays using amyloid precursor proteins with modified β-secretase cleavage sites to monitor β-secretase activity |
| 03/27/2007 | US7196056 A mixture comprising progenitor cells, are stimulated by exposure to a morphogen, tissue-specific cell differentiation and proliferation; tissue-targeted therapy, promoting liver tissue growth |
| 03/27/2007 | US7195926 preparing polyclonal antibodies by immunizing animals with polypeptides under conditions to elicit an antibody response and screening the resultant antigens with the polypeptide to identifying polyclonal antibodies which bind specifically to the polypeptide |
| 03/27/2007 | US7195903 Comprises metallloenzyme which is fibrinolytically active (fibrolase), for use in treating blood clots in situ |
| 03/27/2007 | US7195902 Expression vector comprising nucleotide sequences coding JNK activating phosphatase for use identifying modulator for treatment of inflammatory, arthritic, cardiovascular, respiratory cell proliferative and liver disorders |
| 03/27/2007 | US7195883 Sandwich assays for collagen fragments |
| 03/27/2007 | US7195882 Immunoglobulin for use in detection of norbuprenorphine, norbuprenorphine glucuronide and buprenorphine glucuronide in bodily fluid; drug testing for drug abuse; immunassay |
| 03/27/2007 | US7195866 Production of anti-self antibodies from antibody segment repertoires and displayed on phage |
| 03/27/2007 | US7195765 Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents |
| 03/27/2007 | US7195764 Cancerous disease modifying antibodies |
| 03/27/2007 | US7195763 Treating or preventing infections; polyclonal and monoclonal antibodies |
| 03/27/2007 | US7195762 Density enhanced protein tyrosine phosphatases |
| 03/27/2007 | US7195761 Humanized antibodies that sequester abeta peptide |
| 03/27/2007 | US7195750 Clinical parameters for determining hematologic toxicity prior to radioimmunotherapy |
| 03/27/2007 | CA2375787C Compositions and methods for increasing cholesterol efflux and raising hdl using atp binding cassette transporter protein abc1 |
| 03/27/2007 | CA2275489C Oil bodies and associated proteins as affinity matrices |
| 03/27/2007 | CA2200582C Dna encoding human papillomavirus type 6a |
| 03/27/2007 | CA2141555C Morphogenic protein soluble complex and composition thereof |
| 03/27/2007 | CA2134966C Antibodies with specificity for multiple adhesion molecules |
| 03/22/2007 | WO2007033230A2 Anti-cd3 antibody formulations |
| 03/22/2007 | WO2007033140A2 Prok2 antagonists and methods of use |
| 03/22/2007 | WO2007032560A1 Novel monoclonal antibody and use thereof |
| 03/22/2007 | WO2007032559A1 Novel monoclonal antibody and use thereof |
| 03/22/2007 | WO2007031996A1 Compositions and methods for diagnosing and treating an inflammation |
| 03/22/2007 | WO2007031550A2 Method for preparing immunoglobulin libraries |
| 03/22/2007 | WO2007031277A2 Means and methods for diagnosing endometriosis |
| 03/22/2007 | WO2007031222A2 Identification of tumor-associated antigens for diagnosis and therapy |
| 03/22/2007 | WO2007030937A2 Screening proteinase modulators using a chimeric protein and ski-i proprotein convertase substrates and inhibitors |
| 03/22/2007 | WO2007030930A1 Methods and compositions for modulating tumor cell activity |
| 03/22/2007 | WO2007030890A1 A marker for prolonged rupture of membranes |
| 03/22/2007 | WO2007030889A1 Method of diagnosing pre-eclampsia |
| 03/22/2007 | WO2007014455A9 Cancerous disease modifying antibodies |
| 03/22/2007 | WO2007001851A3 Compositions and methods for the diagnosis and treatment of tumor |
| 03/22/2007 | WO2006138737A3 Methods of purifying anti a beta antibodies |
| 03/22/2007 | WO2006125668A3 Anti-cd16 binding molecules |
| 03/22/2007 | WO2006122786A3 Improved nanobodies™ against tumor necrosis factor-alpha |
| 03/22/2007 | WO2006116631A3 Cancer specific pcna isoform binding antibodies and uses thereof |
| 03/22/2007 | WO2006116592A9 Antibodies with immune effector activity and that internalize in folate receptor alpha-positive cells |
| 03/22/2007 | WO2006114704A3 P-cadherin antibodies |
| 03/22/2007 | WO2006104989A3 Altered antibody fc regions and uses thereof |
| 03/22/2007 | WO2006099141A3 Anti-mesothelin antibodies |